Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9632524rdf:typepubmed:Citationlld:pubmed
pubmed-article:9632524lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0115305lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0001511lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C1272706lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9632524lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9632524pubmed:issue6lld:pubmed
pubmed-article:9632524pubmed:dateCreated1998-7-15lld:pubmed
pubmed-article:9632524pubmed:abstractTextLeukocyte extravasation is governed by the endothelium, expressing a defined pattern of adhesion molecules in response to inflammatory stimuli. Among them, E-selectin, which is expressed in response to interleukin 1 (IL-1) or tumour necrosis factor alpha (TNF-alpha), provides rolling adhesion of the circulating leukocytes, a transient and reversible interaction that initiates leukocyte extravasation. In our experiments, E-selectin expression culminated after 4 to 6 h and declined thereafter. After 24 h a considerable amount of E-selectin was presented, reflecting its continuous expression in different inflammatory skin disorders. After preincubation of the endothelial cells with TNF-alpha together with IL-4 or IL-13, E-selectin mRNA transcription and protein expression were markedly reduced at 8 h and almost abolished at 20 h. In contrast, early E-selectin expression between 2 to 6 h was not significantly impaired. In a rotating adherence assay that mimics physiological shear forces in circulation, preincubation of the endothelial cells with TNF-alpha for 4 and 20 h induced similar adherence of neutrophils, which was largely E-selectin dependent. According to the modified expression kinetics of E-selectin in the presence of IL-4 of IL-13 rolling adhesion was unimpaired at 4 h but significantly diminished after 20 h of preincubation. Similar results were obtained with clones of the cutaneous T cell lymphoma cell line HUT78 highly expressing the E-selectin ligand cutaneous lymphocyte-associated Ag. Together, these data suggest that IL-4 and IL-13 control the rolling adhesion by limiting the period of the induced E-selectin expression and may thereby confine the acute phase of leukocyte emigration.lld:pubmed
pubmed-article:9632524pubmed:languageenglld:pubmed
pubmed-article:9632524pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:citationSubsetIMlld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9632524pubmed:statusMEDLINElld:pubmed
pubmed-article:9632524pubmed:monthJunlld:pubmed
pubmed-article:9632524pubmed:issn1043-4666lld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:MosesSSlld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:WeberLLlld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:EtterHHlld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:EugsterH PHPlld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:AlthausRRlld:pubmed
pubmed-article:9632524pubmed:authorpubmed-author:Santamaria-Ba...lld:pubmed
pubmed-article:9632524pubmed:copyrightInfoCopyright 1998 Academic Press Limited.lld:pubmed
pubmed-article:9632524pubmed:issnTypePrintlld:pubmed
pubmed-article:9632524pubmed:volume10lld:pubmed
pubmed-article:9632524pubmed:ownerNLMlld:pubmed
pubmed-article:9632524pubmed:authorsCompleteYlld:pubmed
pubmed-article:9632524pubmed:pagination395-403lld:pubmed
pubmed-article:9632524pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:meshHeadingpubmed-meshheading:9632524-...lld:pubmed
pubmed-article:9632524pubmed:year1998lld:pubmed
pubmed-article:9632524pubmed:articleTitleIL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression.lld:pubmed
pubmed-article:9632524pubmed:affiliationInstitute of Toxicology of the Swiss Federal Institute of Technology and University of Zurich, CH-8603 Schwerzenbach, Switzerland.lld:pubmed
pubmed-article:9632524pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9632524pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9632524lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9632524lld:pubmed